Ruggeri, Matteo, Michele Basile, Alessandro Armuzzi, and Americo Cicchetti. 2017. “Activity-Based Costing and Budget Analysis of Vedolizumab Versus Conventional Treatments in Ulcerative Colitis and Crohn’s Disease: Analisi Organizzativa E Di Budget Dell’introduzione Di Vedolizumab Vs Terapie Tradizionali in Colite Ulcerosa E Morbo Di Crohn”. Global and Regional Health Technology Assessment 4 (1):88-99. https://doi.org/10.33393/grhta.2017.382.